Search

Your search keyword '"Di Napoli, M"' showing total 516 results

Search Constraints

Start Over You searched for: Author "Di Napoli, M" Remove constraint Author: "Di Napoli, M"
516 results on '"Di Napoli, M"'

Search Results

1. Management of Metastatic Disease in Campania (MAMETIC): An Observational Multicenter Retrospective and Prospective Trial on Palliative Radiotherapy in an Italian Region. Study Protocol

4. PARP Inhibitors in Endometrial Cancer: Current Status and Perspectives

6. Inadequate PROs and HRQoL reporting in phase III advanced genitourinary tumors RCTs

8. Quality-of-life analysis of the MITO-8, MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG study comparing platinum-based versus non-platinum-based chemotherapy in patients with partially platinum-sensitive recurrent ovarian cancer

11. Signs and symptoms of COVID-19 in patients with multiple sclerosis

13. 52P Real-world data of niraparib in platinum sensitive relapsed ovarian cancer: A multicenter experience of the MITO group

16. Detection of disability worsening in relapsing-remitting multiple sclerosis patients: a real-world roving Expanded Disability Status Scale reference analysis from the Italian Multiple Sclerosis Register

17. Sharing real-world experiences to optimize the management of olaparib toxicities: a practical guidance from an Italian expert panel

18. Signs and symptoms of COVID-19 in patients with multiple sclerosis

19. SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study

21. The Italian multiple sclerosis register

22. Cytological diagnosis of Xp11 translocation renal cell carcinoma: An unusual suspect in bone metastases from unknown primary malignancies

25. Disease modifying therapies and Covid‐19 severity in Multiple Sclerosis

26. Regular physical activity postpones age of occurrence of first-ever stroke and improves long-term outcomes.

27. Slow-moving landslide risk assessment combining Machine Learning and InSAR techniques

28. Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis

31. COVID-19 pandemic and burden of non-communicable diseases: An ecological study on data of 185 countries.

32. Call to Action: SARS-CoV-2 and CerebrovAscular DisordErs (CASCADE)

33. Stroke Care Trends During COVID-19 Pandemic in Zanjan Province, Iran. From the CASCADE Initiative: Statistical Analysis Plan and Preliminary Results

34. Correlations between COVID-19 and burden of dementia: An ecological study and review of literature

35. COVID-19 Pandemic and Burden of Non-Communicable Diseases: An Ecological Study on Data of 185 Countries

36. Olaparib as maintenance therapy in patients with BRCA 1–2 mutated recurrent platinum sensitive ovarian cancer: Real world data and post progression outcome

37. Sharing real-world experiences to optimize the management of olaparib toxicities: a practical guidance from an Italian expert panel

38. Detection of disability worsening in relapsing-remitting multiple sclerosis patients: a real-world roving Expanded Disability Status Scale reference analysis from the Italian Multiple Sclerosis Register

40. LBA82 Influenza-like illness and SARS-Cov-2 in the multicenter, prospective, observational INVIDIa-2 study (INfluenza Vaccine Indication During therapy with Immune checkpoint inhibitors: A transversal challenge): A FICOG study

41. Geomorphology of Cinque Terre National Park (Italy).

42. pCRP-mCRP Dissociation Mechanisms as Potential Targets for the Development of Small-Molecule Anti-Inflammatory Chemotherapeutics

43. Absolute risk and predictors of the growth of acute spontaneous intracerebral haemorrhage: a systematic review and meta-analysis of individual patient data

45. Diagnostic accuracy of Hybrid Capture 2 test: Results obtained from internal quality control

46. Monomeric C-reactive protein and cerebral hemorrhage: From bench to bedside

47. Absolute risk and predictors of the growth of acute spontaneous intracerebral haemorrhage: a systematic review and meta-analysis of individual patient data.

48. Quality-of-life analysis of the MITO-8, MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG study comparing platinum-based versus non-platinumbased chemotherapy in patients with partially platinum-sensitive recurrent ovarian cancer

49. Relationship between carotid intima-media thickness and non valvular atrial fibrillation type

50. Long-term tolerability of olaparib tablets as maintenance therapy for platinum-sensitive relapsed ovarian cancer (PSR OC): Phase III SOLO2 trial

Catalog

Books, media, physical & digital resources